Protocol for High Fever Management Not Reducing with IV Paracetamol in Suspected/Confirmed Dengue
Continue paracetamol at appropriate dosing intervals and focus on aggressive fluid management rather than switching antipyretics, as fever control is secondary to preventing plasma leakage and shock in dengue.
Immediate Assessment and Risk Stratification
When fever persists despite IV paracetamol in dengue patients, your priority shifts from fever reduction to identifying the disease phase and preventing complications:
- Determine disease phase: Dengue follows a triphasic course (febrile, critical, recovery). Persistent fever beyond 3-5 days may signal transition to the critical phase where plasma leakage becomes the primary concern 1
- Assess for warning signs indicating need for hospitalization and IV fluids 2:
- Abdominal pain or tenderness
- Persistent vomiting
- Clinical fluid accumulation (ascites, pleural effusion)
- Mucosal bleeding
- Lethargy or restlessness
- Liver enlargement >2 cm
- Rising hematocrit with rapid platelet decline
Fever Management Strategy
Do NOT Switch to NSAIDs in Active Dengue
While recent evidence suggests low-dose ibuprofen may have comparable safety to paracetamol 3, the standard of care remains paracetamol exclusively 4, 5. The contraindication against NSAIDs exists because:
- Thrombocytopenia is a hallmark complication
- Bleeding risk, though potentially overstated, remains a theoretical concern
- No randomized controlled trials support NSAID use in dengue 4
Appropriate Paracetamol Dosing
- Continue paracetamol at proper intervals (every 4-6 hours)
- Verify cumulative daily dose does not exceed hepatotoxic thresholds
- Monitor liver function closely as dengue itself causes hepatitis, and paracetamol is the leading cause of drug-induced liver failure 4
Physical Cooling Measures
- Apply cold compresses 5
- Tepid sponging
- Maintain cool environment
- Light clothing
Primary Management Focus: Fluid Resuscitation
The persistent fever is less concerning than the hemodynamic status. Shift your attention to:
Fluid Management Protocol 2
For patients with warning signs or plasma leakage:
- Initiate isotonic crystalloid fluids at 5-10 mL/kg/hr 5
- Monitor hematocrit serially (every 4-6 hours during critical phase)
- Assess peripheral perfusion continuously
- Adjust fluid rates based on:
- Hematocrit trends
- Urine output (maintain >0.5 mL/kg/hr)
- Vital signs stability
- Clinical evidence of fluid overload
Critical Monitoring Parameters
- Hematocrit: Rising hematocrit indicates hemoconcentration from plasma leakage
- Platelet count: Severe thrombocytopenia (<20,000/μL) with active bleeding requires platelet transfusion
- Liver enzymes: Dengue causes hepatitis; paracetamol adds hepatotoxic risk 4
- Vital signs: Hypotension signals shock requiring aggressive resuscitation
When to Escalate Care
Transfer to intensive care if:
- Severe dengue develops (shock, severe bleeding, organ impairment) 1
- Shock state requiring fluid boluses
- Significant hemorrhage requiring blood product transfusion 5
- Altered mental status
- Severe organ dysfunction
Common Pitfalls to Avoid
- Over-focusing on fever: Fever itself is not dangerous in dengue; plasma leakage and shock are the killers. Mortality in severe dengue is 1-5% 1
- Fluid overload: Both under- and over-resuscitation cause complications 2. Judicious fluid administration requires careful monitoring
- Aspirin use: Absolutely contraindicated due to bleeding risk 5
- Excessive paracetamol: Dengue-associated hepatitis increases vulnerability to paracetamol hepatotoxicity 4
- Premature discharge: The critical phase (days 3-7) is when complications emerge, even as fever defervesces
Diagnostic Confirmation
If not already done:
- RT-PCR for dengue virus (up to day 5 of illness) 1
- Dengue NS1 antigen (early infection)
- IgM/IgG serology (after day 5) 6
The fever magnitude matters less than the phase of illness and presence of warning signs. Your protocol should emphasize close monitoring during the critical phase (typically days 3-7) with appropriate fluid management, rather than aggressive antipyretic escalation 2, 1.